Bone-RADS

Bone Reporting and Data System

Management categories for incidentally detected solitary bone lesions on CT and MRI.

vigenteAmerican College of Radiology2022CT, MRI

1Bone-RADS 1, leave alone 2Bone-RADS 2, follow up or further imaging 3Bone-RADS 3, biopsy or oncology referral

Aplicar o Bone-RADS a um achado

Descreva o achado como no laudo. A resposta aponta uma das categorias publicadas, com a probabilidade e o trecho que a decide.

Categorias

Reescritas a partir da fonte e citadas

1 de 3

Bone-RADS 1, leave alone

Lesion judged clearly benign on CT or MRI - for example one with a definitive benign diagnosis (such as enostosis, non-ossifying fibroma, fibrous dysplasia, enchondroma, subchondral cyst, or hemangioma), confirmed internal macroscopic fat, or fat-matching/cortical-bone-matching signal - so that no additional workup is needed.

CondutaLeave alone: no further imaging, follow-up, or tissue sampling required.

verificadoBone Reporting and Data System (Bone-RADS) for incidentally detected solitary bone lesionsPMC9283187 (Chang CY et al., Skeletal Radiol 2022, Bone-RADS), 'Management options: Bone-RADS' section and Table; lucent / sclerotic-mixed / MRI algorithm sections (e.g., Case 1, 2, 9, 10)

2 de 3

Bone-RADS 2, follow up or further imaging

Indeterminate lesion for which characterization is incomplete on the current study and additional diagnostic information from a different imaging modality is needed (e.g., FDG-PET, bone scan, MRI, CT, chemical-shift or contrast-enhanced sequences, or radiographs).

CondutaPerform a different imaging modality to further characterize the lesion.

verificadoBone Reporting and Data System (Bone-RADS) for incidentally detected solitary bone lesionsPMC9283187 'Management options: Bone-RADS' section and Table; indeterminate-lesion branches of the CT lucent, CT sclerotic/mixed, and MRI algorithms (e.g., Case 8 red marrow assigned Bone-RADS2)

3 de 3

Bone-RADS 3, biopsy or oncology referral

Indeterminate lesion judged appropriate for surveillance with the same imaging modality to detect interval growth or development of worrisome features such as cortical involvement.

CondutaPerform follow-up imaging; the suggested schedule is repeat imaging at 6, 6, and 12 month intervals for a total of 2 years.

verificadoBone Reporting and Data System (Bone-RADS) for incidentally detected solitary bone lesionsPMC9283187 'Management options: Bone-RADS' section and Table (follow-up at 6, 6, 12 months over 2 years)

Lógica de decisão estruturada

{
  "categories": [
    "1",
    "2",
    "3"
  ]
}

Referência, não é dispositivo médico. Confira a publicação primária vigente. O radiologista que assina o laudo continua autor e responsável.